BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 15799743)

  • 1. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa.
    Ozdemir H; Karacorlu M; Karacorlu S
    Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal triamcinolone as a primary therapy in diabetic macular oedema.
    Karacorlu M; Ozdemir H; Karacorlu S; Alacali N; Mudun B; Burumcek E
    Eye (Lond); 2005 Apr; 19(4):382-6. PubMed ID: 15309024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet disease.
    Karacorlu M; Mudun B; Ozdemir H; Karacorlu SA; Burumcek E
    Am J Ophthalmol; 2004 Aug; 138(2):289-91. PubMed ID: 15289142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
    Lin JM; Chiu YT; Hung PT; Tsai YY
    Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
    Saraiva VS; Sallum JM; Farah ME
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion.
    Williamson TH; O'Donnell A
    Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
    Konstantopoulos A; Williams CP; Luff AJ
    Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema.
    Ozdemir H; Karacorlu M; Karacorlu SA
    Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
    Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
    Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide.
    Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL
    Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: longterm management and outcome.
    Angunawela RI; Heatley CJ; Williamson TH; Spalton DJ; Graham EM; Antcliffe RJ; Stanford MR
    Acta Ophthalmol Scand; 2005 Oct; 83(5):595-9. PubMed ID: 16187999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion.
    Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F
    Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.
    Massin P; Audren F; Haouchine B; Erginay A; Bergmann JF; Benosman R; Caulin C; Gaudric A
    Ophthalmology; 2004 Feb; 111(2):218-24; discussion 224-5. PubMed ID: 15019365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
    Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
    Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study.
    Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A
    Acta Ophthalmol Scand; 2005 Oct; 83(5):600-4. PubMed ID: 16188000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
    Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
    Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.